Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evolving Applications for Sintered Porous Plastics

Published: Thursday, January 02, 2014
Last Updated: Thursday, January 02, 2014
Bookmark and Share
A technical article from Porvair Filtration Group documents the evolution of how sintered porous plastics have been used in industrial applications to their incorporation today in novel Chromatin Immunoprepitation (ChIP) assay kits used by scientists at the forefront of epigenetics research.

Sintered porous plastics are produced by heat sintering together porous polymers such as polyethylene and polypropylene. The ability to produce plastics with a well-defined pore size distribution, combined with a material exhibiting excellent robustness and chemical resistance, has meant that sintered porous plastics have been widely adopted for a diverse range of applications. Typical industrial applications for sintered porous plastics include water and air filtration, sound attenuation, fragrance emanation, vacuum table beds, powder fluidisation and battery venting.

The authors describe how growing use of these materials in the stringently regulated life science and medical markets has necessitated development of fully traceable production processes to produce contamination-free porous plastics with very low levels of leachables.  Further a leading edge application of sintered porous plastics is described. The Chromatrap® chromatin immunoprecipitation (ChIP) assay kit uses a novel porous plastic material to which Protein A or Protein G are chemically bound. The Chromatrap® solid phase porous structure is able to capture antibody-tagged DNA-protein complexes associated with cancers. This technology is helping pave the way for development of targeted cancer treatments and personalised medicines.

For a copy of "Sintered Porous Plastic: the evolution from Industrial applications to the Chromatrap ChIP Assay Test kit” please contact Porvair Filtration Group on +44-1489-864330 / +1-804-550-1600, or email info@porvairfiltration.com.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Porvair Filtration Group Receives Queen’s Award for Enterprise in International Trade
This award had been made in recognition of Porvair’s substantial growth in overseas business, achieving increased year-on-year growth in sales of exported products over the past three years.
Tuesday, April 21, 2015
Biomedical Researcher wins Microplate Catalogue Prize Draw
A scientist at the Genomics CoreLab of the NIHR Biomedical Research Centre at Addenbrooke's Hospital (Cambridge, UK) has won Porvair Sciences' latest free prize draw for people registering online for the company's 2010-2011 Microplate Catalogue.
Wednesday, January 26, 2011
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!